Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
TERMINATED
NA
12 participants
INTERVENTIONAL
2013-04-30
2018-10-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Clinical Investigation of the Multifocal IOL POD F GF in Cataracteous Eyes
NCT04699266
Prospective Clinical Study of Preoperative and Postoperative Unilateral Mild Cataract Patients
NCT04266847
Evaluating Presbyopia-Correcting IOLs in Complex Cataract Cases With Anterior Segment Abnormalities
NCT07321756
Visual Performance With a Hydrophobic Aspheric Monofocal IOL
NCT03819582
Comparison Between Bilateral Multifocal Intraocular Lenses and Pseudophakic Monovision
NCT02155348
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
TRIPLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Multifocal IOL
Phacoemulsification and IOL inserted following cataract surgery
Cataract surgery
Standard IOL
Phacoemulsification and IOL inserted following cataract surgery
Cataract surgery
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Cataract surgery
Other Intervention Names
Discover alternative or legacy names that may be used to describe the listed interventions across different sources.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Male or female, aged 18 - 45.
* Cataract operation required in one eye only, either due to the presence of cataract affecting visual function, or in combination with surgery which is likely to cause visually significant cataract.
* Expected visual improvement in operable eye of at least 6/12.
* Fellow eye with a VA of at least 6/9.
* Astigmatism of 1.0D or less.
* Target of emmetropia in the operated eye.
* Intact posterior capsule with planned implantation into the capsular bag.
* IOL power required 10 - 30D.
Exclusion Criteria
* Significant diabetic retinopathy.
* Macular off retinal detachment with metamorphopsia or poor visual prognosis.
* Other macula or ophthalmic pathology affecting macula function resulting in poor visual prognosis.
* Pregnancy, lactating or planned pregnancy during the study period.
18 Years
45 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Oxford University Hospitals NHS Trust
OTHER
University of Oxford
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Robert E MacLaren, DPhil
Role: PRINCIPAL_INVESTIGATOR
University of Oxford
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Oxford University Hospitals NHS Trust
Oxford, Oxfordshire, United Kingdom
Stoke Mandeville Hospital
Aylesbury, , United Kingdom
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
BVMP2013
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.